TOKYO -- Blackstone will acquire CMIC, a leading Japanese contract research organization that helps drugmakers develop new treatments, the U.S. investment fund manager announced Monday.
Business deals
Blackstone to buy Japan clinical trial company CMIC
U.S. investment fund manager to facilitate new drug development by overseas players
Blackstone sees the health care and pharmaceutical sectors as key priorities. © Reuters
Read Next
Latest on Business deals
